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Background: The NINDS-Canadian Stroke Network (NINDS-CSN) recommended a neuropsychological battery of
three protocols to diagnose vascular cognitive impairment (VCI), however, due to culture and language differences,
the battery cannot be directly used in China. Validation of the battery in mandarin Chinese is lacking. Our study
investigated the reliability and validity of the adapted Chinese versions of the battery in stroke patients with high
probability of VCI.
Methods: Fifty mild stroke patients (median of National Institute of Health Stroke Scale [NIHSS] score, 2) and 50
stroke-free normal controls were recruited. All subjects’ demographics, clinical history, and stroke severity were
recorded. The NINDS-CSN neuropsychological protocols were adapted into the Chinese versions. External validity,
defined as the ability of the protocol summary scores to differentiate stroke patients from controls, was determined
using the area under the curve (AUC) of the receiver operating characteristics curve. We also evaluated internal
consistency and intra-rater reliability.
Results: Stroke patients performed significantly poorer than controls on all three protocols (F statistics between
24.9 and 31.4, P < 0.001). External validity evaluated by AUCs was 0.88 (95% confidence interval [CI], 0.81-0.95), 0.88
(95% CI, 0.81-0.94), and 0.86 (95% CI, 0.79-0.94) for the 60-min, 30-min and 5-min protocols, respectively. Cronbach’s
alpha of the cognitive tests was 0.87 for all subjects. Intra-rater reliability was acceptable with intraclass correlation
coefficients 0.90, 0.83 and 0.75 for the 60-min, 30-min and 5-min protocols, respectively.
Conclusions: The adapted Chinese versions of three NINDS-CSN neuropsychological protocols were valid and
reliable for assessing VCI in Chinese patients with mild stroke.
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Vascular cognitive impairment (VCI) represents the
spectrum of cognitive impairment associated with evi-
dent stroke or subclinical vascular brain injury [1].
Around 2/3 of stroke patients may suffer from VCI [2,3],
consequently they are more prone to have decline of
quality of life [4], depression [5], and poor survival [6].
Considering the clinical importance of VCI, the National* Correspondence: caloriey@163.com; xfliu2@vip.163.com
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adian Stroke Network (NINDS-CSN) recommended a
neuropsychological battery of three protocols (60-min,
30-min and 5-min) for early identification and diagnosis
of VCI [7]. Because there are language and culture dif-
ferences across countries, validation of the NINDS-CSN
neuropsychological protocols is critical for the imple-
mentation of VCI diagnosis. Currently, Korean [3], Hong
Kong [8], France [9] and Singapore [10] have validated
these protocols in stroke or transient ischemic attack pa-
tients. However, there is no validation study in the popu-
lation of mainland China, where stroke and dementiahis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Adapted Chinese versions of NINDS-CSN
neuropsychological protocols
Cognitive tests 60-min 30-min 5-min
Executive/activation
ANT [16] √ √
WAIS-III Digit symbol-
coding test [17]
√ √ MoCA subtests [7]
TMT A [18] √ - 5’- Immediate recall
TMT B [18] √ - 5’- Delayed recall
Language 5’- Recognition
Modified BNT [19] √ - 6’- Orientation
Visuospatial 9’- ANT
RCFT copy [20] √ -
Memory
HVLT-R delayed recall [21] √ √
RCFT delayed recall [20] √ -
Neuropsychiatric/depressive
symptoms
NPI-Q [14] - -
GDS [15] - -
Abbreviations: ANT Animal naming test, TMT Trail making test, BNT Boston
naming test, RCFT Rey-Osterrieth Complex Figure Test, HVLT-R Revised Hopkins
verbal learning test, NPI-Q Neuropsychiatric Inventory questionnaire,
GDS Geriatric Depression Scale.
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[11,12].
Considering that stroke patients had high probability of
VCI after 3 months post-stroke, we developed a Chinese
adaption for the NINDS-CSN battery, and aimed to inves-
tigate the external validity and reliability of the adapted
Chinese versions for assessing VCI in post-stroke patients.
Methods
Subjects
Our study was a case–control study. Cases were post-
stroke patients who fulfilled the following criteria: aged
50 years or older; patients with an evident ischemic stroke
at least 3 months before; absent of traumatic brain injury,
Parkinson disease, or psychiatric disorders known to influ-
ence cognitive function; and without motor, sensory or
speech impediment hindering their participation in cogni-
tive tests. Stroke patients were recruited at the out-patient
clinic in a teaching hospital in Nanjing, China. An available
informant who was knowledgeable of the patient’s cogni-
tive status was also required. Patients with a history of
hemorrhagic stroke, a pre-existing diagnosis of dementia,
or a Mini-Mental State Examination (MMSE) score ≤10
were excluded [13].
Controls were recruited through advertisement on bul-
letin boards at our out-patient clinic and in a commu-
nity; they were enrolled if they scored >24 on the MMSE
at screening without historical records of stroke or tran-
sient ischemic attack. We attempted to match cases and
controls on age and sex. All subjects gave written in-
formed consents and the study was approved by the in-
stitutional review board at Jinling Hospital.
We collected all subjects’ demographic data (age, sex,
education, and handedness), clinical history (stroke,
transient ischemic attack, myocardial infarction, atrial
fibrillation, hypertension, hyperlipidemia, diabetes melli-
tus, past smoking and alcohol abuse), and physical ex-
aminations (body mass index, blood pressure, and stroke
severity measured by National Institutes of Health
Stroke Scale [NIHSS]).
Neuropsychological protocols
Three VCI neuropsychological protocols were recom-
mended by the NINDS-CSN, with different protocols
serving different purposes [7]. The 60-min protocol was
developed for studies that required a breakdown of cogni-
tive functions by domain; and the four tested domains
were as follows: executive/activation, language, visuo-
spatial, and memory. In addition, neuropsychiatric/depres-
sive symptoms were assessed using the neuropsychiatric
inventory questionnaire [14] and the geriatric depression
scale [15]; Tests of the 30-min protocol were selected
within the 60-min protocol for clinical screening, includ-
ing executive/activation and memory domains. The 5-minprotocol was designed as a quick-screening tool, consist-
ing of selected subtests from the Montreal Cognitive As-
sessment (MoCA)-a 5-word immediate, delayed and
recognition memory test, a 6-item orientation task and an
animal naming test. Total score was calculated in the same
way as Wong et al. study [8]. The tests and scales that
composed the adapted Chinese versions of NINDS-CSN
neuropsychological protocols were shown in Table 1.
For ease of administration, we adapted the neuro-
psychological protocols into Chinese versions. For trail
making test (TMT) B, where the individual is required
to draw lines alternately between numbers and letters,
the English letters were replaced by Chinese characters
according to the “heavenly stems and earthly branches”.
The Hopkins verbal learning test was adapted with refer-
ence to the Chinese frequency list. One of the items
“Opal” was uncommon in Chinese, which was changed
to “diamond”. Modifications were also made to the
Boston naming test (BNT). Based on the 15-item
version, two items with low frequency in Chinese (“octo-
pus” and “beaver”) were replaced by Chinese alternatives
“sea horse” and “mouse”.
Two supplemental tests-the Chinese version of MMSE
and MoCA, Beijing version (MoCA-BJ) were also evalu-
ated in our study. Subjects were considered cognitively
impaired using cut-off points of MMSE as 17/18 for illit-
erates, 19/20 for individuals with 1 to 6 years of educa-
tion, and 24/25 for those with 7 or more years of




Age, years 60.4 ± 7.4 62.8 ± 7.8 0.118
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of MoCA were 13/14, 19/20 and 24/25 for illiterates, in-
dividuals with 1 to 6 years of education, and those with
7 or more years of education, respectively [24].Male, no. (%) 24 (48%) 29 (58%) 0.316
Education 0.038
0-6 years 7 (14%) 11 (22%) -
7-12 years 28 (56%) 33 (66%) -
>12 years 15 (30%) 6 (12%) -
Right-handedness, no. (%) 48 (96%) 48 (96%) 1.000
Myocardial infarction, no. (%) 2 (4%) 2 (4%) 1.000
Atrial fibrillation, no. (%) 1 (2%) 1 (2%) 1.000
Hypertension, no. (%) 12 (24%) 39 (78%) <0.001
Hyperlipidemia, no. (%) 5 (10%) 13 (26%) 0.037
Diabetes mellitus, no. (%) 5 (10%) 18 (36%) 0.002
Smoking, no. (%) 12 (24%) 24 (48%) 0.012
Alcohol abuse, no. (%) 20 (40%) 9 (18%) 0.098
Body mass index, kg/m2 24.2 ± 2.5 24.8 ± 3.1 0.270
Systolic blood pressure, mmHg 125.5 ± 18.5 133.6 ± 12.3 0.013
Diastolic blood pressure, mmHg 79.2 ± 10.3 80.9 ± 9.9 0.403
Recurrent stroke, no. (%) - 16 (32%) -
NIHSS score - 2 (0–4) -
Abbreviations: NIHSS National Institutes of Health Stroke Scale.Statistical analysis
To compare demographic and clinical data of stroke pa-
tients and controls, independent sample t test for nor-
mal distributed continuous data, χ2 tests or Fisher’s
exact tests for categorical data, and trend test for ordinal
data were used as appropriate. Effect sizes were calcu-
lated with Cohen’s d tests. Cohen’s d effect sizes of 0.2,
0.5, and 0.8 were considered small, medium, and large,
respectively [25].
To determine the external validity of three adapted
Chinese versions of NINDS-CSN protocols, tests scores
were converted to standardized z scores. TMT time
scores were multiplied by −1 after standardization. Aver-
aged z scores were calculated by the 60-, 30-, and 5-min
protocols. Z scores between stroke patients and controls
on each protocol were compared with education ad-
justed. Receiver operating characteristic (ROC) curve
analyses with area under the curve (AUC) were used to
define how well the three protocols differentiated stroke
patients from controls. An AUC of 50% corresponds to a
random classification and 100% a perfect classification
[26]. Meanwhile, to evaluate MoCA-BJ and MMSE as a
screening tool in stroke patients, the Kappa statistic was
used to assess test agreement [27] with the 60-min
protocol. Patients were considered cognitively impaired
if they performed 1.5 SDs below the control mean on at
least one cognitive domain [1].
Reliability of the protocols was assessed by the internal
consistency between individual cognitive tests. The
intra-rater reliability was evaluated using intraclass cor-
relation coefficients (ICC) [28]. The internal consistency
for cognitive tests was estimated by the Cronbach’s alpha
statistic [29]. A two-sided P value of less than 0.05 was
considered to indicate statistical significance. All statis-
tical analyses were performed with the use of SPSS Sta-
tistics for Windows, version 17.0.Results
Fifty stroke patients and 50 controls were recruited. In
stroke patients, the median NIHSS score on admission
was 2 (interquartile range [IQR], 0–4); the median inter-
val between stroke onset and cognitive assessment was
206 days (IQR, 94 days-272 days). The median consum-
ing time was 1.2 h (IQR, 0.9 h-1.5 h).
The clinical characteristics in each group were sum-
marized in Table 2. Comparing with controls, stroke
patients were less educated with a higher proportion of
hypertension, hyperlipidemia, diabetes mellitus, andsmoking as well as higher systolic blood pressure at
cognitive assessment.
Group comparisons of neuropsychological assessment
were shown in Table 3. Stroke patients had significantly
lower scores than controls on all individual tests and
showed more neuropsychiatric/depressive symptoms,
with effect sizes ranging from 0.41 to 1.60. Summary
scores of the three neuropsychological protocols in
stroke patients were significantly lower than controls (F
statistics: 31.1, 31.4 and 24.9 for the 60-min, 30-min and
5-min protocol, respectively, P <0.001).
External validity evaluated by AUC for the 60-min
protocol was 0.88 (95% confidence interval [CI], 0.81-
0.95), for the 30-min protocol was 0.88 (95% CI, 0.81-
0.94), and for the 5-min protocol was 0.86 (95% CI,
0.79-0.94). AUCs of MoCA-BJ and MMSE were 0.88
(0.81-0.95) and 0.75 (0.65-0.85), respectively. Sensitivity
and specificity for various summary z scores of the three
NINDS-CSN neuropsychological protocols were shown
in Table 4. High sensitivity with relatively good specifi-
city, the highest sum of sensitivity and specificity, and
high specificity with relatively good sensitivity were
given. A cut-off value of z = −0.014 was optimal for the
60-min protocol, with sensitivity of 74% and specificity
of 90%. ROC curves for the three protocol summary
scores were presented in Figure 1.
Table 3 Comparison of neuropsychological assessment






ANT 17.2 ± 4.0 11.9 ± 4.1 <0.001 1.31
WAIS-III Digit symbol-
coding
22.4 ± 7.9 3.4 ± 6.6 <0.001 1.24
TMT A time (sec) 45.7 ± 15.5 90.7 ± 59.1 0.001 1.04
TMT B time (sec) 108.2 ± 42.3 176.4 ± 97.4 0.009 0.92
Domain z score −1.01
Language
Modified BNT 11.4 ± 2.2 8.8 ± 2.7 0.003 1.03
Domain z score −0.92
Visuospatial
RCFT copy 34.6 ± 1.8 30.2 ± 6.9 0.002 0.88
Domain z score −0.80
Memory
HVLT-R delayed recall 7.6 ± 2.6 4.5 ± 2.7 <0.001 1.16
RCFT delayed recall 18.6 ± 6.3 11.9 ± 8.8 <0.001 0.89
Domain z score −0.93
Neuropsychiatric/
depressive symptoms
NPI-Qa 2 (0–11) 4 (0–29.5) 0.008 0.41
GDSa 2 (1–3) 3 (1–7.25) 0.024 0.63
Supplemental tests
MMSE 28.6 ± 1.1 26.3 ± 3.2 <0.001 0.94
MoCA-BJ 23.8 ± 2.9 17.9 ± 4.4 <0.001 1.59
Protocol summary
scores
60-min 0.46 ± 0.45 −0.49 ± 0.72 <0.001 1.57
30-min 0.53 ± 0.67 −0.53 ± 0.65 <0.001 1.60
5-min 0.41 ± 0.47 −0.42 ± 0.71 <0.001 1.38
aData shown in median (Interquartile range); bModel controlled for years
of education.
Abbreviations: ANT Animal naming test, TMT Trail making test, BNT Boston
naming test, RCFT Rey-Osterrieth Complex Figure Test, HVLT-R Revised
Hopkins verbal learning test, NPI-Q Neuropsychiatric Inventory questionnaire,
GDS Geriatric Depression Scale, MMSE Mini-Mental State Examination,
MoCA-BJ Montreal Cognitive Assessment-Beijing version.
Table 4 Sensitivity and specificity (%) for various z scores
of the NINDS-CSN neuropsychological battery
NINDS-CSN protocol Summary z score Sensitivity Specificity
60-min −0.222 62.0 96.0
−0.014 74.0 90.0
0.412 90.0 60.0
30-min −0.372 58.0 96.0
0.103 86.0 76.0
0.393 94.0 60.0
5-min 0.122 76.0 86.0
0.227 86.0 76.0
0.379 90.0 66.0
Figure 1 ROC curves of the three adapted Chinese versions of
the NINDS-CSN VCI protocols in discriminating stroke patients
from controls.
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patients were considered to be cognitively impaired on
the MMSE, whereas 90% of patients were impaired on
the MoCA-BJ. MMSE identified 19.4% of the patients
who were cognitively impaired by the 60-min protocol,
and MoCA-BJ identified 96.8%. Kappa statistic values
were 0.030 (P = 0.384) between MMSE and MoCA-BJ,
0.154 (P = 0.041) between the 60-min protocol and
MMSE, and 0.208 (P = 0.041) between the 60-min
protocol and MoCA-BJ.
Cronbach’s alpha of the cognitive tests was 0.87 for all
subjects. Based on a repeated rating after a mean durationof 63.6 days (SD = 27.9) in 12 subjects (2 stroke cases and
10 controls), intra-rater reliability as measured by ICC
(95% CI) was 0.90 (0.66-0.97) for the 60-min protocol,
0.83 (0.41-0.95) for the 30-min protocol, and 0.75 (0.14-
0.93) for the 5-min protocol.
Discussion
The adapted Chinese versions of three NINDS-CSN
neuropsychological protocols were valid in discriminating
stroke patients from cognitively normal controls, with
good reliability of reproduction and internal consistency.
The lack of satisfactory criteria for VCI diagnosis and its
preventable nature urged the establishment of NINDS-
CSN neuropsychological battery [7]. International effort
has been made by validation studies from France [9],
Hong Kong [8], and Singapore [10]. Our study was con-
sistent with previous studies, also showing good validity
and reliability of the protocols for diagnosing VCI. In
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studies were derived from Chinese patients, however, our
previous Hong Kong study validated the protocols in
Cantonese, whereas our Chinese versions were adapted in
Mandarin Chinese, and modifications were made to TMT,
BNT, and the HVLT-R according to the culture in main-
land China. Moreover, we provided reliability data in our
study which gave more information for assessing VCI in
stroke patients.
As expected, stroke patients had a higher proportion of
vascular risk factors, and showed poorer cognitive per-
formance and more neuropsychiatric/depressive symp-
toms than controls. A similar conclusion was drawn by
researchers in the Singapore [10] and our previous Hong
Kong [8] validation studies. The French study [9] (Clini-
calTrials.gov ID: NCT01339195) was supposed to end in
August 2013, yet no results have been published so far.
In China, more than 2 million people had vascular de-
mentia [11] with a prevalence of 1.5% in people more
than 65 years of age [30]. Stroke doubles the risk of inci-
dent dementia [31], thus, it is important to assess post-
stroke cognitive function. For patients with mild stroke,
the Chinese versions can differentiate them from con-
trols very well, with AUCs of 0.88, 0.88 and 0.86 for the
60-min, 30-min and 5-min protocol, respectively. Two
previous studies also demonstrated adequate discrimin-
atory power (corresponding AUCs were 0.90, 0.89 and
0.79 in the Singapore study [10]; 0.79, 0.79 and 0.76 in
our previous Hong Kong study [8]). Nonetheless, clini-
cians should pay attention that these protocols were not
applicable to stroke patients with severe impairment of
vision, language or consciousness [3]. Moreover, those
who had little or no experience in using a pen or in
drawing (e.g. illiterate elderly persons) were less moti-
vated for written tasks like TMT and RCFT. Further im-
proved versions were required for the illiterate elders.
Patients with impaired cognition on at least one do-
main can be identified by MMSE and MoCA at a pro-
portion of 19.4% and 96.8%, respectively. However, they
both reached a borderline agreement with the 60-min
protocol (P = 0.041), and MMSE showed a ceiling effect
with high scores in stroke patients (mean score, 26.3 ±
3.2), which was also observed in Tombaugh TN, et al.
study [32]. Therefore, MoCA could be a more sensitive
test than MMSE for VCI screening in post-stroke pa-
tients [33].
There were several limitations of our study. First, our
cases were patients who suffered relatively mild stroke.
Therefore, our results may not be representative of VCI
patients with more severe strokes or cognitive disorders
related to other vascular brain diseases. However, this
on the other hand highlighted the sensitivity of these
protocols, for that cognitive impairment can be detected
even in patients with mild stroke. Second, the patientgroup had a higher proportion of hypertension, hyperlip-
idemia, diabetes mellitus, and smoking, and these factors
would impact cognitive performance of the NINDS-CSN
battery. However, they had not been matched when
choosing the control group, hence, the battery should be
applied with caution that in stroke patients with a
greater burden of vascular risk factors, a lower reliability
and a higher discrimilinatory ability was likely to hap-
pen, in consideration of the contributions of cognitive
dysfunction from related vascular risk factors. Third,
controls were selected based on normal MMSE without
excluding substantial small vessel diseases that are com-
mon in VCI. Therefore we not completely excluded sub-
jects with mild cognitive impairment in this group.
Fourth, the sample size of 50 was determined empiric-
ally, with reference to our previous validation study in
Hong Kong [8]. However, according to Schmidt et al., if
true validity is 0.50, criterion reliability is 0.80, the selec-
tion ratio is 1.00, and a two-tailed test is used, a sample
size of 49 is required for power 90% [34], thus our sam-
ple size would be adequate. Fifth, the intra-rater reliabil-
ity analysis was based on a sample of only 12 subjects,
which would possibly introduce biases towards better
consistency. Sixth, controls had higher levels of educa-
tion than stroke patients, yet this was adjusted in the
statistical analyses.Conclusions
Our study suggested that the adapted Chinese versions
of NINDS-CSN neuropsychological protocols were valid
and reliable for assessing VCI in mainland Chinese
stroke patients. Our study would contribute to the inter-
national effort for the development of VCI common
standards, and help early identification and diagnosis of
VCI in China.
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